ARCHIVES

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

This article is from The Cancer Letter archive.

Vol. 32 No. 14 | April 14, 2006

Download PDF Visit The Full Archive

Related Articles

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

December 26, 2014

Patient Advocacy: NBCC Urges Funding For Treatment Of Women Screened In CDC Program

July 17, 1998

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997

NCI advisory panel recommends funding a 10-year Human Cancer Genome Project with $1.35 billion in new money.

March 18, 2005

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991